NABOTA®

Botulinum toxin type A  
Indication: Glabella Lines (Approved in KR, US, CA, EU), Post Stroke Upper Limb Spasticity, Crow's feet, Blepharospasm, Benign Masseteric Hypertrophy (Approved in KR)
- Nabota is the only 900kDa Neurotoxin approved in the US and EU since Botox.- It has demonstrated both efficacy and safety, even with long-term and repetitive administration, through large-scale global clinical studies involving more than 2,000 subjects in the US and Europe.- Produced using Hi-PURETM technology, a patented purification process, resulting over 98% 900 kDa Botulinum toxin with minimal impurity presence